Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-24
    E.g., 2018-02-24

Articles

Pages

7408 items
12:27 PM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Avid raises $23M in follow-on

Contract development and manufacturing company Avid Bioservices Inc. (NASDAQ:CDMO) raised $23.2 million through the sale of 10.3 million shares at $2.25 in a follow-on underwritten by Wells Fargo, H.C. Wainwright and Roth. The figures include...
12:25 PM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Ascendis raises $225M in bumped-up follow-on

Endocrinology company Ascendis Pharma A/S (NASDAQ:ASND) raised $225 million on Feb. 22 through the sale of 3.9 million ADSs at $57 in a bumped-up follow-on underwritten by J.P. Morgan, BofA Merrill Lynch, Credit Suisse, Wells...
12:25 PM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Aimmune raises $176M in bumped up follow-on

Allergy play Aimmune Therapeutics Inc. (NASDAQ:AIMT) raised $176 million on Feb. 22 through the sale of 5.5 million shares at $32 in a bumped-up follow-on. Underwriters were BofA Merrill Lynch, Cantor Fitzgerald, Piper Jaffray, Credit...
12:25 PM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Ra raises $50.4M in follow-on

Complement-mediated disease company Ra Pharmaceuticals Inc. (NASDAQ:RARX) raised $50.4 million on Feb. 14 through the sale of 8.4 million shares at $6 in a follow-on underwritten by Credit Suisse, Jefferies, BMO Capital Markets and SunTrust...
12:24 PM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Pieris raises $50.6M in follow-on

Anticalin company Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) raised $50.6 million through the sale of 6.3 million shares at $8 in a follow-on underwritten by Jefferies, Cowen and Evercore ISI. The figures include the sale of an...
12:24 PM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Pacific raises $30M in follow-on

Sequencing company Pacific Biosciences of California Inc. (NASDAQ:PACB) raised $30 million on Feb. 13 through the sale of 12.5 million shares at $2.40 in a follow-on underwritten by Cantor. The price is a 6% discount to...
12:24 PM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

miRagen raises $38.5M in follow-on

MicroRNA company miRagen Therapeutics Inc. (NASDAQ:MGEN) raised $38.5 million on Feb. 8 through the sale of 7 million shares at $5.50 in a follow-on underwritten by Jefferies, Evercore, Deutsche Bank, Wedbush and Oppenheimer. The price is...
7:25 AM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Amicus raises $300M in bumped-up follow-on

Amicus Therapeutics Inc. (NASDAQ:FOLD) raised $300 million on Feb. 15 through the sale of 19.4 million shares at $15.50 in an upsized follow-on underwritten by J.P. Morgan, Goldman Sachs, Cowen, Leerink and BofA Merrill Lynch....
7:25 AM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Celularity unveils size of series A

Celularity Inc. (Warren, N.J.) revealed on Feb. 15 that it has raised more than $250 million in series A funding and assets from Celgene Corp. (NASDAQ:CELG), three other biotechs and private investors. The cell therapy,...
7:24 AM, Feb 23, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Kallyope raises $66M in series B

Kallyope Inc. (New York, N.Y.) raised $66 million on Feb. 22 in a series B round. Existing investors Lux Capital, The Column Group, Polaris Partners, Illumina Ventures and Alexandria Venture Investments participated, as did new...

Pages